Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Dec 01 2022

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-01-2022-12

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 01-Dec-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Diclofenac Sodium Topical Solution USP, 2% w/w.

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases